The Glucagonoma Syndrome: A Review of its Features and Discussion of New Perspectives

Stabile, 1997, Islet cell tumors, Gastroenterologist, 5, 213

Wilder, 1927, Carcinoma of the islets of the pancreas, JAMA, 89, 348, 10.1001/jama.1927.02690050014007

Rothman, 1925, Uber hauterscheinungen bei bosartigen geschwulsten innerer organe, Arch Dermatol Syphilol, 149, 99, 10.1007/BF02297811

Becker, 1942, Cutaneous manifestations of internal malignant tumors, Arch Dermatol Syphilol, 45, 1068, 10.1001/archderm.1942.01500120037004

Hamperl, 1952, Uber Argyrophile Zellen, Virchows Archiv, 321, 482

Zhdanov, 1956, Diabetes in a case of tumors of the islets of the pancreas, Arch Pathol, 18, 92

McGavran, 1966, A glucagonsecreting alpha-cell carcinoma of the pancreas, N Engl J Med, 274, 1408, 10.1056/NEJM196606232742503

Unger, 1961, Glucagon antibodies and immunoassay for glucagon, J Clin Invest, 40, 1280, 10.1172/JCI104357

Wilkinson, 1973, Necrolytic migratory erythema with carcinoma of the pancreas, Trans St Johns Dermatol Soc, 59, 244

Mallinson, 1974, A glucagonoma syndrome, Lancet, 2, 1, 10.1016/S0140-6736(74)91343-9

Thivolet, 1974, Erytheme cutane migrateur avec necrose epidermique superficielle au cours d’une pancreatite chronique, Bull Soc Franc Dermatol Syphilol, 81, 415

Schwartz, 1997, Glucagonoma and pseudoglucagonoma syndromes, Int J Dermatol, 36, 81, 10.1046/j.1365-4362.1997.00042.x

Mullans, 1998, Iatrogenic necrolytic migratory erythema: a case report and review of nonglucagonoma- associated necrolytic migratory erythema, J Am Acad Dermatol, 38, 866, 10.1016/S0190-9622(98)70478-5

Wermers, 1996, The glucagonoma syndrome. Clinical and pathologic features in 21 patients, Medicine, 75, 53, 10.1097/00005792-199603000-00002

Prinz, 1981, Clinical aspects of glucagon-producing islet cell tumors, Am J Gastroenterol, 76, 125

Lewis, 1979, The glucagonoma syndrome, Int J Dermatol, 18, 17, 10.1111/j.1365-4362.1979.tb01904.x

Mozell, 1990, Functional endocrine tumors of the pancreas. Clinical presentation, diagnosis, and treatment, Curr Probl Surg, 27, 301, 10.1016/0011-3840(90)90025-Z

Stacpoole, 1981, The glucagonoma syndrome. Clinical features, diagnosis, and treatment, EndocrRev, 2, 347

Vinik, 1989, Treatment of endocrine tumors of the pancreas, Endocrinol Metab Clin North Am, 18, 483, 10.1016/S0889-8529(18)30379-7

Manes, 1995, Rare presentation of endocrine pancreatic tumour: a case of glucagonoma without necrolytic migratory erythema?, Ital J Gastroenterol, 27, 248

Wynick, 1993, The glucagonoma syndrome, Clin Dermatol, 11, 93, 10.1016/0738-081X(93)90103-J

Boden, 1989, Glucagonomas and insulinomas, Gastroenterol Clin North Am, 18, 831, 10.1016/S0889-8553(21)00444-1

Edney, 1990, Glucagonoma syndrome is an underdiagnosed entity, Am J Surg, 160, 625, 10.1016/S0002-9610(05)80761-5

Weil, 1985, Gastroenteropancreatic endocrine tumors, Klin Wochenschr, 63, 433, 10.1007/BF01731493

Shupak, 1978, The glucagonoma syndrome, J Dermatol Surg Oncol, 4, 242, 10.1111/j.1524-4725.1978.tb00419.x

Pedersen, 1976, Necrolytic migratory erythema and glucagon cell tumour of the pancreas: the glucagonoma syndrome, Acta Derm Venereol (Stockh), 56, 391

Sweet, 1974, A dermatosis specifically associated with a tumour of pancreatic alpha cells, Br J Dermatol, 90, 301, 10.1111/j.1365-2133.1974.tb06406.x

Katz, 1979, Necrolytic migratory erythema, presenting as candidiasis, due to a pancreatic glucagonoma, Cancer, 44, 558, 10.1002/1097-0142(197908)44:2<558::AID-CNCR2820440224>3.0.CO;2-S

Hansen, 1992, Dermatitis and nutritional deficiency, Arch Dermatol, 128, 1389, 10.1001/archderm.1992.01680200099017

Haneke, 1984, Acquired zinc deficiency mimicking glucagonoma dermatitis. Histology and electron microscopy, Z Hautkr, 59, 902

Kurzrock, 1995, Cutaneous paraneoplastic syndromes in solid tumors, Am J Med, 99, 662, 10.1016/S0002-9343(99)80254-X

Kasper, 1992, Necrolytic migratory erythema: unresolved problems in diagnosis and pathogenesis. A case report and literature review, Cutis, 49

Ranchoff, 1985, Necrolytic migratory erythema-like dermatitis with malabsorption, Cleve Clin Q, 52, 81, 10.3949/ccjm.52.1.81

Franchimont, 1982, Angioplastic necrolytic migratory erythema. Unique association of necrolytic migratory erythema, extensive angioplasia, and high molecular weight glucagon-like polypeptide, Am J Der- matopathol, 4, 485

Rappaport, 1995, 45-year-old man with dermatitis and weight loss, Mayo Clin Proc, 70, 785, 10.4065/70.8.785

Rockl, 1977, Staphylodermia superficialis circinata. The 5th obligatory cutaneous paraneoplasia, Hautarzt, 28, 178

Hunt, 1991, Necrolytic migratory erythema: dyskeratotic dermatitis, a clue to early diagnosis, J Am Acad Dermatol, 24, 473, 10.1016/0190-9622(91)70076-E

Ohyama, 1982, Ultrastructural studies of necrolytic migratory erythema, Arch Dermatol, 118, 679, 10.1001/archderm.1982.01650210059020

Parker, 1984, Glucagonoma syndrome. Case report and literature review, J Dermatol Surg Oncol, 10, 884, 10.1111/j.1524-4725.1984.tb01341.x

Kahan, 1977, Necrolytic migratory erythema. Distinctive dermatosis of the glucagonoma syndrome, Arch Dermatol, 113, 792, 10.1001/archderm.1977.01640060088011

el Darouti, 1996, Necrolytic acral erythema: a cutaneous marker of viral hepatitis C, Int J Dermatol, 35, 252, 10.1111/j.1365-4362.1996.tb02997.x

Vandersteen, 1985, Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultra- structural study, J Am Acad Dermatol, 12, 1032, 10.1016/S0190-9622(85)70133-8

Frankton, 1996, Gastrointestinal endocrine tumors. Glucagonomas, Baillieres Clin Gastroenterol, 10, 697, 10.1016/S0950-3528(96)90019-6

Ruttman, 1980, Pancreatic glucagonoma with and without the syndrome: immunocyto- chemical study of 5 tumour cases and review of the literature, Virchows Archiv A Pathol Anat Histol, 388, 51, 10.1007/BF00430676

Davies, 1992, A glucagonoma without necrolytic migratory erythema, Pancreas, 7, 398, 10.1097/00006676-199205000-00021

Parr, 1985, Glucagonoma without cutaneous manifestations, Postgrad Med J, 61, 737, 10.1136/pgmj.61.718.737

Boden, 1987, Insulinoma and glucagonoma, Semin Oncol, 14, 253

Kaplan, 1986, Endocrine tumors of the pancreas and their clinical syndromes, SurgAnnu, 18, 181

Domen, 1980, The glucagonoma syndrome: report of a case, Arch Intern Med, 140, 262, 10.1001/archinte.1980.00330140120030

Huang, 1997, A persistent periorificial eruption, Arch Dermatol, 133, 909,912, 10.1001/archderm.1997.03890430129019

Holmes, 1991, Reversal of a neurologic paraneoplastic syndrome with octreotide (sandostatin) in a patient with glucagonoma, Am J Med, 91, 434, 10.1016/0002-9343(91)90164-S

Khandekar, 1987, Response of glucagonoma syndrome to lomustine, Cancer Treat Rep, 70, 433

Lambrecht, 1987, Retrobulbar neuritis as the first sign of the glucagonoma syndrome, Int Ophthalmol, 11, 13, 10.1007/BF02027892

Stone, 1997, Self-assessment examination of the American Academy of Dermatology, J Am Acad Dermatol, 37

Croughs, 1972, Glu- cagonoma as part of the polyglandular adenoma syndrome, Am J Med, 52, 690, 10.1016/0002-9343(72)90059-9

Leichter, 1986, Glucagonoma: an endocrine neoplasm with a unique dermatosis-necrolytic migratory erythema, 143

Long, 1993, Suprabasal acantholysisand unusual feature of necrolytic migratory erythema, Clin Exp Dermatol, 18, 464, 10.1111/j.1365-2230.1993.tb02253.x

Magro, 1997, Cutaneous manifestations of nutritional deficiency states and gastrointestinal disease, 353

Chong, 1992, Necrolytic migratory erythema in glucagonoma syndrome, J Dermatol, 19, 369, 10.1111/j.1346-8138.1992.tb03241.x

Perniciaro, 1998, Apoptosis with positive direct immunofluorescence findings in a patient with necrolytic migratory erythema, Cutis, 62, 129

Kheir, 1986, Histologic variation in the skin lesions of the glucagonoma syndrome, Am J Surg Pathol, 10, 445, 10.1097/00000478-198607000-00001

Wilkinson, 1990, Necrolytic migratory erythema: association with neuroendocrine tumour with predominant insulin secretion, Br J Dermatol, 123, 801, 10.1111/j.1365-2133.1990.tb04201.x

Waeber, 1997, In vivo and in vitro effects of somatostatin and insulin on glucagon release in a human glucagonoma, Clin Endocrinol, 46, 637, 10.1046/j.1365-2265.1997.1560967.x

Rosch, 1992, Localization of pancreatic endocrine tumors by endoscopic ultrasonography, N Engl J Med, 326, 1721, 10.1056/NEJM199206253262601

Cavallo-Perin, 1988, A combined glucagonoma and VIPoma syndrome. First pathologic and clinical report, Cancer, 62, 2576, 10.1002/1097-0142(19881215)62:12<2576::AID-CNCR2820621221>3.0.CO;2-5

Pearse, 1971, Neural crest origin of the endocrine polypeptide (APUD) cells of the gastrointestinal tract and pancreas, Gut, 12, 783, 10.1136/gut.12.10.783

Murlin, 1923, Aqueous extracts of the pancreas. Influence on the carbohydrate metabolism of depancreatized animals, J Biol Chem, 56, 253, 10.1016/S0021-9258(18)85619-8

Sutherland, 1948, Origin and distribution of the hyperglycemic-glycogenolytic factor of the pancreas, J Biol Chem, 175, 663, 10.1016/S0021-9258(18)57183-0

Staub, 1953, Purification and crystallization of hyperglycemic-glycogenolytic factor, Science, 117, 628, 10.1126/science.117.3049.628

Holst, 1996, Glucagon, glucagon-like peptide-1 and their receptors: an introduction, Acta Physiol Scand, 157, 309, 10.1046/j.1365-201X.1996.32261000.x

Montenegro-Rodas, 1981, Glucagonoma tumors and syndrome, Curr Probl Cancer, 6, 3, 10.1016/S0147-0272(81)80014-1

Lefebvre, 1995, Glucagon and its family revisited, Diabetes Care, 18, 715, 10.2337/diacare.18.5.715

Smith, 1996, Rapid resolution of necrolytic migratory erythema after glucagonoma resection, J Surg Oncol, 61, 306, 10.1002/(SICI)1096-9098(199604)61:4<306::AID-JSO15>3.0.CO;2-3

Wermers, 1996, Clinical spectrum of hyperglucagonemia associated with malignant neuroendocrine tumors, Mayo Clin Proc, 71, 1030, 10.4065/71.11.1030

Peterson, 1984, Glucagonoma syndrome: in vitro evidence that glucagon increases epidermal arachidonic acid, J Am Acad Dermatol, 11, 468, 10.1016/S0190-9622(84)70192-7

Marinkovich, 1995, Necrolytic migratory erythema without glucagonoma in patients with liver disease, J Am Acad Dermatol, 32, 604, 10.1016/0190-9622(95)90345-3

Doyle, 1979, Hyperglucagonaemia and necrolytic migratory erythema in cirrhosis–possible pseudoglucagonoma syndrome, Br J Dermatol, 100, 581

Tanner, 1994, Erythema necroticans migrans ohne glukagonom, Hautarzt, 45, 480, 10.1007/s001050050109

Thorisdottir, 1994, Necrolytic migratory erythema: a report of three cases, J Am Acad Dermatol, 30, 324, 10.1016/S0190-9622(94)70033-8

Kelly, 1989, Necrolytic migratory erythema with elevated plasma enteroglucagon in celiac disease, Gastroenterology, 96, 1350, 10.1016/S0016-5085(89)80023-X

Goodenberger, 1979, Necrolytic migratory erythema without glucagonoma, Arch Dermatol, 115, 1429, 10.1001/archderm.1979.04010120027012

Walker, 1982, Atypical necrolytic migratory erythema in association with a jejunal adenocarcinoma, J R Soc Med, 75, 134

Konstantinow, 1998, Erythema necrolyticum migrans after rectal adenocarcinoma, Hautarzt, 49, 591, 10.1007/s001050050795

Massa, 1988, Necrolytic migratory erythema associated with odontogenic infection: an example of pseudoglucagonoma syndrome, Cutis, 41, 190

Bencini, 1994, Necrolytic migratory erythema without glucagonoma in a heroin-dependent patient, Dermatology, 189, 72, 10.1159/000246789

Barber, 1976, Skin rash in patient receiving glucagon, Lancet, 2, 1138, 10.1016/S0140-6736(76)91118-1

Ossowski, 1995, Pseudoglucagonoma syndrome: case report, therapeutic possibilities and hypotheses on the etiology, Hautarzt, 46, 173, 10.1007/s001050050232

Williams, 1985, Treatment with danazol and plasma glucagon concentration, Br Med J, 291, 1155, 10.1136/bmj.291.6503.1155

Marchesini, 1993, Glucagon and amino acid disposal in normal man and in patients with cirrhosis, Ital J Gastroenterol, 25, 93

Donowitz, 1975, Glucagon secretion in acute and chronic pancreatitis, Ann Intern Med, 83, 778, 10.7326/0003-4819-83-6-778

Kasper, 1991, Necrolytic migratory erythema without glucagonoma versus canine superficial necrolytic dermatitis: is hepatic impairment a clue to pathogenesis?, J Am Acad Dermatol, 25, 534, 10.1016/0190-9622(91)70236-U

Boden, 1977, Familial hyperglucagonemia—an autosomal dominant disorder, N Engl J Med, 296, 534, 10.1056/NEJM197703102961003

Gross, 1993, Superficial necrolytic dermatitis (necrolytic migratory erythema) in dogs, Vet Pathol, 30, 75, 10.1177/030098589303000110

Walton, 1986, Ulcerative dermatosis associated with diabetes mellitus in the dog: a report of four cases, J Am Anim Hosp Assoc, 22, 79

Blackford, 1991, Necrolytic migratory erythema without glucagonoma: the role of dietary essential fatty acids, Br J Dermatol, 125, 460, 10.1111/j.1365-2133.1991.tb14773.x

Sinclair, 1997, Necrolytic migratory erythema and zinc deficiency, Br J Dermatol, 136, 783, 10.1111/j.1365-2133.1997.tb03672.x

Norton, 1979, Amino acid deficiency and the skin rash associated with glucagonoma, Ann Intern Med, 91, 213, 10.7326/0003-4819-91-2-213

Greenberger, 1994, Disorders of absorption, 1386

Amon, 1976, The glucagonoma syndrome (necrolytic migratory erythema) and zinc, N Engl J Med, 295, 962, 10.1056/NEJM197610212951717

Dohlsten, 1985, Immunological studies in a patient with the glucagonoma syndrome, Acta Med Scand, 218, 251, 10.1111/j.0954-6820.1985.tb08856.x

Khandekar, 1979, Neurological involvement in glucagonoma syndrome, Cancer, 44, 2014, 10.1002/1097-0142(197912)44:6<2014::AID-CNCR2820440608>3.0.CO;2-M

Bordi, 1990, Immunohistochemical localization of factor X-like antigen in pancreatic islets and their tumours, Virchows Archiv A Pathol Anat Histol, 416, 397, 10.1007/BF01605144

Reyes-Govea, 1989, Response of glucagonomas to surgical excision and chemotherapy, Am Surg, 55, 523

Altimari, 1986, Use of somatostatin analog (SMS 201–995) in the glucagonoma syndrome, Surgery, 100, 989

Elsborg, 1985, Effect of somatostatin in necrolytic migratory erythema of glucagonoma, Acta Med Scand, 218, 245, 10.1111/j.0954-6820.1985.tb08855.x

Siller, 1994, Glucagonoma syndrome with increased lactate dehydrogenase isoenzymes: octreotide treatment, Australas J Dermatol, 34, 11, 10.1111/j.1440-0960.1994.tb01792.x

Jockenhovel, 1994, The long-acting somatostatin analogue octreotide alleviates symptoms by reducing posttranslational conversion of pre- pro-glucagon to glucagon in a patient with malignant glucagonoma, but does not prevent tumor growth, Clin Investig, 72, 127, 10.1007/BF00184589

Rosenbaum, 1989, Octreotide (SMS 201–995) in the treatment of metastatic glucagonoma: report of one case and review of the literature, Digestion, 42, 116, 10.1159/000199835

Santangelo, 1986, Somatostatin analog-induced remission of necrolytic migratory erythema without changes in plasma glucagon concentration, Pancreas, 1, 464, 10.1097/00006676-198609000-00013

Tomassetti, 1998, Slow-release lanreotide treatment in endocrine gastrointestinal tumors, Am J Gastroenterol, 93, 1468, 10.1111/j.1572-0241.1998.465_q.x

van der Loos, 1987, Successful treatment of glucagonoma-related necrolytic migratory erythema with dacarbazine, J Am Acad Dermatol, 16, 468, 10.1016/S0190-9622(87)70063-2

Awrich, 1981, Dimethyltriazenoimidazole carboxamide therapy of islet cell carcinoma of the pancreas, J Surg Oncol, 17, 321, 10.1002/jso.2930170404

Broder, 1973, Pancreatic islet cell carcinoma. Results of therapy with streptozotocin in 52 patients, Ann Intern Med, 79, 108, 10.7326/0003-4819-79-1-108

Arnold, 1989, Liver transplantation for primary and secondary hepatic apudomas, Br J Surg, 76, 248, 10.1002/bjs.1800760311

Makowka, 1989, Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas, Surg Gynecol Obstet, 168, 107

Alsina, 1990, Liver transplant for metastatic neuroendocrine tumor, J Clin Gastroenterol, 12, 533, 10.1097/00004836-199010000-00009

Shepard, 1991, Treatment of necrolytic migratory erythema in glucagonoma syndrome, J Am Acad Dermatol, 25, 925, 10.1016/0190-9622(91)70285-A

Fujita, 1986, A functional study of a case of glucagonoma exhibiting typical glucagonoma syndrome, Cancer, 57, 860, 10.1002/1097-0142(19860215)57:4<860::AID-CNCR2820570429>3.0.CO;2-U

Bewley, 1996, Successful treatment of a patient with octreotide-resistant necrolytic migratory erythema, Br J Dermatol, 134, 1101, 10.1111/j.1365-2133.1996.tb07951.x